DnB Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,054
Closed -$209K 1242
2025
Q4
$209K Sell
2,054
-244,585
-99% -$19.6M ﹤0.01% 715
2025
Q3
$13.5M Buy
246,639
+33,071
+15% +$1.65M 0.05% 241
2025
Q2
$11.3M Sell
213,568
-32,191
-13% -$1.64M 0.05% 250
2025
Q1
$10.6M Buy
245,759
+18,902
+8% +$957K 0.05% 252
2024
Q4
$12.7M Buy
226,857
+43,006
+23% +$2.68M 0.06% 224
2024
Q3
$12.5M Sell
183,851
-56,032
-23% -$3.16M 0.06% 221
2024
Q2
$10.1M Buy
239,883
+76,847
+47% +$4.23M 0.05% 221
2024
Q1
$11.3M Buy
163,036
+18,618
+13% +$1.18M 0.06% 216
2023
Q4
$10.7M Sell
144,418
-2,763
-2% -$181K 0.06% 237
2023
Q3
$10M Buy
147,181
+46,153
+46% +$3.92M 0.06% 223
2023
Q2
$9.49M Sell
101,028
-19,059
-16% -$1.49M 0.05% 246
2023
Q1
$8.14M Sell
120,087
-30,312
-20% -$1.95M 0.05% 261
2022
Q4
$7.45M Sell
150,399
-100,683
-40% -$4.11M 0.05% 272
2022
Q3
$8.16M Buy
251,082
+79,858
+47% +$3.29M 0.06% 243
2022
Q2
$6.74M Buy
171,224
+9,896
+6% +$529K 0.05% 282
2022
Q1
$11.3M Buy
161,328
+5,677
+4% +$415K 0.07% 218
2021
Q4
$12.1M Buy
155,651
+23,318
+18% +$2.06M 0.07% 207
2021
Q3
$12.6M Buy
132,333
+37,578
+40% +$3.97M 0.08% 197
2021
Q2
$11.8M Buy
94,755
+62,294
+192% +$7.43M 0.08% 202
2021
Q1
$4.28M Buy
32,461
+14,013
+76% +$1.92M 0.03% 361
2020
Q4
$2.44M Buy
18,448
+1,613
+10% +$195K 0.02% 420
2020
Q3
$1.72M Buy
16,835
+1,318
+8% +$114K 0.02% 425
2020
Q2
$1.35M Buy
15,517
+1,585
+11% +$127K 0.02% 462
2020
Q1
$808K Sell
13,932
-2,501
-15% -$203K 0.01% 513
2019
Q4
$1.52M Buy
16,433
+3,025
+23% +$266K 0.01% 506
2019
Q3
$1.21M Buy
13,408
+660
+5% +$75.2K 0.01% 519
2019
Q2
$1.5M Buy
+12,748
New +$1.28M 0.02% 469

Other funds holding EXAS

DnB Asset Management's EXAS Position: Q1 2026 in Review

DnB Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2,054 shares — an estimated $209K sold.

DnB Asset Management first reported a position in EXAS in Q2 2019 and held it in 27 quarters. The position peaked at $13.5M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • DnB Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • DnB Asset Management sold 2,054 Exact Sciences shares in Q1 2026, an estimated $209K.
  • DnB Asset Management first reported a position in Exact Sciences in Q2 2019 and held it in 27 quarters.
  • DnB Asset Management's Exact Sciences position peaked at $13.5M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.